发明名称 |
METHOD OF TREATING PAIN UTILIZING CONTROLLED RELEASE OXYMORPHONE PHARMACEUTICAL COMPOSITIONS AND INSTRUCTION ON DOSING FOR RENAL IMPAIRMENT |
摘要 |
The invention pertains to a method of using oxymorphone in the treatment of pain by providing a patient with an oxymorphone dosage form and informing the patient or prescribing physician that the bioavailability of oxymorphone is increased in patients with renal impairment. |
申请公布号 |
US2014329847(A1) |
申请公布日期 |
2014.11.06 |
申请号 |
US201414336753 |
申请日期 |
2014.07.21 |
申请人 |
ENDO PHARMACEUTICALS INC. |
发明人 |
Ahdieh Harry |
分类号 |
A61K31/485;A61K47/10;A61K47/02;A61K47/38;A61K47/36;A61K47/26 |
主分类号 |
A61K31/485 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating pain in a renally impaired patient comprising administering a pharmaceutical composition comprising about 5 mg to about 80 mg of oxymorphone or a pharmaceutically acceptable salt thereof as the sole active ingredient and a controlled release matrix, wherein the renally impaired patient is administered a dose of oxymorphone or a pharmaceutically acceptable salt thereof that is less than the dose administered to a comparable patient without renal impairment. |
地址 |
Malvern PA US |